# OnCo record her2-pet (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/her2-pet/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "her2-pet" ;
  schema:name "HER2 PET"@en ;
  schema:description "HER2 PET is a PET scan using radiolabelled trastuzumab or smaller HER2 binders to map HER2 across all metastases at once."@en ;
  schema:url <https://onco.cc/technologies/her2-pet/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://doi.org/10.1093/annonc/mdv577> ;
  onco:status "phase-2" ;
  onco:cancers <https://onco.cc/cancers/breast-her2-positive/>, <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/gastric/> ;
  onco:sections <https://onco.cc/fronts/imaging/>, <https://onco.cc/fronts/adcs/> ;
  onco:technologies <https://onco.cc/technologies/pet/>, <https://onco.cc/technologies/immuno-pet/> ;
  onco:targets <https://onco.cc/targets/her2/> ;
  onco:trials <https://onco.cc/trials/nct07527806/>, <https://onco.cc/trials/nct06369831/>, <https://onco.cc/trials/nct05619016/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-gebhart-ann-oncol/> .